Clinical Trials List
Protocol NumberCINC424G12201
Completed
2019-12-01 - 2025-12-31
Phase II
Recruiting1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- YUNG-LI YANG Division of Others -
- 張修豪 Division of Pediatrics
- 周書緯 Division of Pediatrics
- SHIANN-TANG JOU Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2-4 participants
-
Global
42 participants
